Sign in

CIK 0000875320

  • Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
043039129
Phone
+1 617-341-6393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,307,135
in 1 filing, $6.3M under 10b5-1 plans

Net −$6,307,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kewalramani Reshma −$6.3M CEO & President sold 12% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-05-01 Schneider Jennifer Director Grant or award +796 1,718
2025-05-01 SACHS BRUCE I Director Grant or award · Stock Option (Right to Buy) +2,398 2,398
2025-05-01 MCKENZIE DIANA Director Grant or award +796 3,232
2025-05-01 MCKENZIE DIANA Director Returned to the company −1,001 2,231
2025-05-01 MCKENZIE DIANA Director Grant or award · Deferred Stock Units +1,001 6,991.48
2025-05-01 Lagarde Michel Director Grant or award · Stock Option (Right to Buy) +2,398 2,398
2025-05-01 Garber Alan M Director Grant or award +398 6,872
2025-05-01 Garber Alan M Director Grant or award · Stock Option (Right to Buy) +1,199 1,199
2025-05-01 CARNEY LLOYD Director Grant or award +796 7,115
2025-05-01 Bhatia Sangeeta N. Director Grant or award 10b5-1 +796 5,231
2025-04-15 Upadhyay Suketu Director Grant or award · Deferred Stock Units +71.61 $497.51 $36K 1,474.6
2025-04-15 SACHS BRUCE I Director Grant or award · Deferred Stock Units +95.48 $497.51 $47K 15,240.46
2025-03-13 ALTSHULER DAVID EVP, Chief Scientific Officer Sale 10b5-1 −3,231 $510.00 $1.6M 23,281
2025-03-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Sale 10b5-1 −3,298 $500.00 $1.6M 51,671
2025-03-10 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale 10b5-1 −3,242 $499.99 $1.6M 51,239
2025-03-10 ALTSHULER DAVID EVP, Chief Scientific Officer Sale 10b5-1 −3,231 $500.00 $1.6M 26,512
2025-03-04 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale 10b5-1 −4,058 $485.49 $2.0M 54,481
2025-03-03 ALTSHULER DAVID EVP, Chief Scientific Officer Sale 10b5-1 −3,231 $490.00 $1.6M 29,743
2025-02-27 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale 10b5-1 −530 $475.34 $252K 58,539
2025-02-27 Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. Sale 10b5-1 −2,650 $475.34 $1.3M 19,352

Page 13 of 18 · 344 trades